Skip to main content
. 2023 Jul 21;13:11789. doi: 10.1038/s41598-023-39003-x

Figure 2.

Figure 2

Expression of ATP1B1, ATP1A1, and SLC12A2. (A) Expression of ATP1B1, ATP1A1, and SLC12A2 in the E109 cochlea. No expression of ATP1B1, ATP1A1, and SLC12A2 expressions was detected in spiral ligament fibrocytes. (B) Expression of ATP1B1, ATP1A1, and SLC12A2 in E115 cochlea. While SLC12A2 expression could not be observed in the spiral ligament fibrocytes, no ATP1B1 and ATP1B1 expression could be detected at this stage. (C) Expression of ATP1B1, ATP1A1, and SLC12A2 in E120 cochlea. At this stage, ATP1B1 expression is observed in type II and IV spiral ligament fibrocytes (asterisk in C). In contrast, no ATP1A1 expression was detected at this stage. (D) Expression of ATP1B1, ATP1A1, and SLC12A2 in the E120 cochlea. At P0, ATP1B1, ATP1A1, and SLC12A2 expression was observed in type II and IV fibrocytes. The nuclei were counterstained with Hoechst (blue). Scale bar 100 µm, StV stria vascularis, II type II fibrocytes, IV type IV fibrocytes. (A–D) Basl turns.